The U.S. Food and Drug Administration (FDA) has approved NJOY LLC to market four menthol-flavored e-cigarette products in the United States. This marks the first time non-tobacco flavored e-cigarette products have received FDA authorization. The decision was based on a rigorous scientific review that found benefits to adult smokers outweigh the risks to youth.
The approved products include NJOY Ace Pod Menthol 2.4%, NJOY Ace Pod Menthol 5%, NJOY Daily Menthol 4.5%, and NJOY Daily Menthol 6%. These products are prefilled, non-refillable e-cigarette vape fluid carriers called pods for use with authorized Ace vaping devices or as prefilled, non-refillable disposable e-cigarettes.
NJOY, based in Scottsdale, Arizona, was one of the first companies to sell e-cigarettes in the U.S. The company’s initial success came with the NJOY KING, a disposable e-cigarette designed to resemble a traditional cigarette.
The FDA emphasized that the approval only applies to these specific products and not to other menthol-flavored e-cigarettes. The agency continues to monitor the marketing of NJOY’s products and will take action if any rules or regulations are violated.
While e-cigarettes are considered a healthier alternative to smoking due to fewer contaminants in their aerosols compared to cigarette smoke, they still pose health risks. E-cigarette use exposes individuals to nicotine, a highly addictive substance that can have negative effects on blood pressure and artery health.
Inhaling nicotine can lead to various side effects such as coughing, throat irritation, heartburn, and indigestion. Prolonged use of e-cigarettes has been associated with eye surface alterations and vision impairment.
The FDA’s decision to authorize these menthol-flavored e-cigarette products underscores the importance of providing sufficient scientific evidence to justify marketing authorization. The agency will continue to prioritize public health while monitoring the impact of these products on consumers.
Source link
